Management of long QT syndrome-Reference-Cited by-同舟云学术

Management of long QT syndrome

Published:2005-07 Issue:7 Volume:2 Page:346-351
ISSN:1743-4297
Container-title:Nature Clinical Practice Cardiovascular Medicine
language:en
Short-container-title:Nat Rev Cardiol

Author:

Schwartz Peter J

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://www.nature.com/articles/ncpcardio0239.pdf

Reference30 articles.

1. Schwartz PJ et al. (1975) The long Q-T syndrome. Am Heart J 89: 378–390

2. Schwartz PJ et al. (2000) The long QT syndrome. In: Cardiac Electrophysiology: From Cell to Bedside, edn 3, 597–615 (Eds Zipes DP and Jalife J) Philadelphia: WB Saunders

3. Moss AJ et al. (2000) Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 101: 616–623

4. Priori SG et al. (2004) Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 292: 1341–1344

5. Wang Q et al. (1995) SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80: 805–811

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence From Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes, Transgenic Rabbits, and Patients;Circulation;2024-08-13

2. The impact of genetics on the long QT syndrome: myth or reality?;Current Opinion in Cardiology;2023-01-30

3. Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology;International Journal of Cardiology;2022-10

4. Exploring mutation specific beta blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers;Channels;2022-08-10

5. Ictal neural oscillatory alterations precede sudden unexpected death in epilepsy;Brain Communications;2022-03-01